Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea
· Delayed Price · Currency is KRW 161,900
-7,900 (-4.65%)
Last updated: Mar 9, 2026, 2:44 PM KST
Daewoong Pharmaceutical Revenue
Daewoong Pharmaceutical had revenue of 411.83B KRW in the quarter ending September 30, 2025, with 14.88% growth. This brings the company's revenue in the last twelve months to 1.54T, up 8.83% year-over-year. In the year 2024, Daewoong Pharmaceutical had annual revenue of 1.42T with 3.44% growth.
Revenue (ttm)
1,541.65B
Revenue Growth
+8.83%
P/S Ratio
1.21
Revenue / Employee
937.74M
Employees
1,644
Market Cap
1,865.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,422.68B | 47.35B | 3.44% |
| Dec 31, 2023 | 1,375.33B | 95.24B | 7.44% |
| Dec 31, 2022 | 1,280.09B | 127.12B | 11.03% |
| Dec 31, 2021 | 1,152.98B | 97.55B | 9.24% |
| Dec 31, 2020 | 1,055.42B | -58.00B | -5.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GC Biopharma | 1,934.38B |
| Celltrion Pharm | 274.73B |
| Hanall Biopharma | 154.05B |
| Chong Kun Dang Pharmaceutical | 1,680.99B |
| Ildong Pharmaceutical | 575.66B |
| Daewoong | 2,055.93B |
| DongKook Pharmaceutical | 894.93B |
| Boryung | 1,028.99B |
Daewoong Pharmaceutical News
- 1 year ago - Sun Pharma launches FEXUCLUE 40 mg in India for treatment of Erosive Esophagitis - Business Upturn